Fluorine in PDB, part 233 (files: 9281-9320),
PDB 8gua-8hlr
Experimental structures of coordination spheres of Fluorine (F) in bioorganic
molecules from X-Ray and NMR experiments. Coordination spheres were calculated with 5.0 Angstroms radius
around Fluorine atoms. PDB files: 9281-9320 (PDB 8gua-8hlr).
-
8gua (F: 3) - Cryo-Em Structure of Cancer-Specific PI3KALPHA Mutant E542K in Complex with Byl-719
-
8gub (F: 3) - Cryo-Em Structure of Cancer-Specific PI3KALPHA Mutant H1047R in Complex with Byl-719
-
8gud (F: 3) - Cryo-Em Structure of Cancer-Specific PI3KALPHA Mutant E545K in Complex with Byl-719
-
8gut (F: 1) - Cryo-Em Structure of Lei-CB2-Gi Complex
-
8gvj (F: 3) - Crystal Structure of Cmet Kinase Domain Bound By D6808
-
8gvz (F: 1) - Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil
Other atoms:
Zn (2);
-
8gw8 (F: 3) - The Human PTH1 Receptor Bound to An Intracellular Biased Agonist
-
8gwm (F: 1) - Sars-Cov-2 E-Rtc Bound with Mmp-NSP9 and Gmppnp
Other atoms:
Zn (8);
-
8gxg (F: 1) - The Crystal Structure of Sars-Cov-2 Main Protease in Complex with 14A
-
8gzc (F: 2) - Crystal Structure of EP300 Hat Domain in Complex with Compound 10
Other atoms:
Zn (6);
-
8h3g (F: 6) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) E166V Mutant in Complex with Inhibitor Enstrelvir
Other atoms:
Cl (2);
-
8h3k (F: 6) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Other atoms:
Cl (2);
-
8h3l (F: 12) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I and E166V) in Complex with Inhibitor Enstrelvir
Other atoms:
Cl (4);
-
8h4y (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) F140L Mutant in Complex with Inhibitor Nirmatrelvir
-
8h51 (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I and E166V) in Complex with Inhibitor Nirmatrelvir
-
8h57 (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) A193P Mutant in Complex with Inhibitor Nirmatrelvir
-
8h59 (F: 3) - A Fungal Map Kinase in Complex with An Inhibitor
-
8h5f (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) L167F Mutant in Complex with Inhibitor Nirmatrelvir
-
8h5p (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Nirmatrelvir
-
8h6n (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Mutant (T21I) in Complex with Protease Inhibitor Nirmatrelvir
-
8h77 (F: 6) - HSP90-Ahr-P23-XAP2 Complex
-
8h7w (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Mutant (S144A) in Complex with Protease Inhibitor Nirmatrelvir
-
8h82 (F: 3) - Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Mutant (E166V) in Complex with Protease Inhibitor Nirmatrelvir
-
8hb0 (F: 1) - Structure of Human SGLT2-MAP17 Complex with TA1887
Other atoms:
Na (1);
-
8hbf (F: 1) - Structure of Human Soluble Guanylate Cyclase in the No+Rio State at 3.1 Angstrom
Other atoms:
Mg (2);
Fe (1);
-
8hbk (F: 3) - The Crystal Structure of Sars-Cov-2 3CL Protease in Complex with Ensitrelvir
Other atoms:
Cl (1);
-
8hdh (F: 1) - Structure of Human SGLT2-MAP17 Complex with Canagliflozin
Other atoms:
Na (1);
-
8he7 (F: 2) - Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor
-
8he8 (F: 3) - Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor
-
8hef (F: 6) - The Crystal Structure of Deuterated S-217622 (Ensitrelvir) Bound to the Main Protease (3CLPRO/Mpro) of Sars-Cov-2
Other atoms:
Cl (2);
-
8hej (F: 6) - Crystal Structure of Transthyretin in Complex with A Covalent Inhibitor Trans-Styrylpyrazole
Other atoms:
Br (4);
-
8hf8 (F: 6) - Human Ppar Delta Ligand Binding Domain in Complex with A Synthetic Agonist V1
-
8hgk (F: 28) - Crystal Structure of Human Clpp in Complex with ZK53
Other atoms:
Br (14);
Mg (5);
-
8hhu (F: 2) - Crystal Structure of the Sars-Cov-2 Main Protease in Complex with SY110
-
8hkn (F: 8) - Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
-
8hko (F: 2) - Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Rucaparib
-
8hkq (F: 12) - Ion Channel
Other atoms:
Na (1);
K (11);
Zn (4);
-
8hks (F: 4) - Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Pamiparib(Bgb-290)
-
8hlj (F: 2) - Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Olaparib (AZD2281)
-
8hlr (F: 8) - Human Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to Fluzoparib (SHR3162)
Page generated: Wed Nov 13 08:14:08 2024
|
